About the Startup
Tubulis is a Munich-based biotech company developing antibody-drug conjugate (ADC) technologies and oncology therapeutics for targeted cancer treatment.
Frequently Asked Questions
What type of funding round did Tubulis raise?
Tubulis raised a series-c round.
How much did Tubulis raise in its series-c?
Tubulis raised $308,000,000 USD in its series-c.
When did Tubulis raise its series-c?
Tubulis raised its series-c on 2025-10-16.
Who invested in Tubulis's series-c?
The investors in Tubulis's series-c are: Venrock Healthcare Capital Partners, Wellington Management, Ascenta Capital, Nextech Invest, EQT Life Sciences, Frazier Life Sciences, Andera Partners, Deep Track Capital, Bayern Kapital, Fund+, OCCIDENT, Seventure Partners, High-Tech Gründerfonds (HTGF).
What type of investment was Tubulis's series-c?
Tubulis's series-c was a equity investment.